Juvenile Inflammatory Rheumatism (JIR) Cohorte
This important study, called the JIR-cohort, is collecting information about children and young people in the UK who have different types of juvenile inflammatory rheumatisms, which are conditions like arthritis. Doctors want to learn more about how these illnesses affect young people over many years. The study will look closely at the medicines patients take, including newer treatments designed to calm down the immune system. Researchers will check if these treatments are effective at controlling the disease and if they cause any side effects. By collecting this information regularly, at least once a year, the study aims to better understand how these conditions develop and how different treatments work in real life. This will help doctors make better choices about care and improve the health of young people with these conditions in the future.
At a glance
What is this study about?
This study is like a special long-term health record for children and young people in the UK who have certain types of arthritis. These conditions are called 'juvenile inflammatory rheumatisms'. The main idea behind this study is for doctors to keep a close eye on how these conditions develop over time and how well different treatments work. They are especially interested in newer medications that help to calm down the body's immune system, which can sometimes mistakenly attack healthy joints and tissues.
By carefully collecting information from a lot of patients, the researchers can spot patterns. For example, they can see which treatments are most effective at reducing pain and swelling, and which ones might cause side effects. This helps them understand the pros and cons of different treatments in real-world situations, not just in a laboratory setting.
The information gathered includes details about a patient's diagnosis, the medicines they're taking, any problems or side effects they experience, and how their condition changes over the years. This isn't just for one patient; it's a big collection of information from many patients. The goal is to use this combined knowledge to improve the care and treatment options for all young people living with juvenile inflammatory rheumatisms in the future.
Key takeaways
- This study collects information about UK children and young people with juvenile arthritis.
- It aims to understand how well treatments work and their side effects over time.
- Participation means your routine health information is recorded for research.
- You will continue to have your regular doctor's appointments, at least once a year.
- There are no new treatments or extra visits involved in this study.
- Your contribution helps future patients with similar conditions.
Who may be eligible?
To be part of this study, you need to be a child or young person who has been diagnosed with a juvenile inflammatory disease, like a form of arthritis. The condition must have started when you were 18 years old or younger.
The most important thing is that you and your parent or legal guardian agree to take part. This involves giving your consent (permission) according to UK rules and laws about health studies.
You cannot join the study if you, or your parent/guardian for younger children, do not give permission to participate. It's completely your choice, and no one should feel pressured to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Have you been diagnosed with a juvenile inflammatory disease, like a type of arthritis?
- Did your condition start before you turned 19 years old?
- Are you, or your parent/guardian (if you're under 16), happy to give permission to take part?
- Are you able to attend your regular check-ups at least once a year?
What does participation involve?
If you join this study, it's mostly about your doctor collecting extra information during your regular appointments. An authorised doctor or nurse will fill out a special form with details about your condition, your treatment, and how you are doing. This will happen during or shortly after your usual clinic visit.
Once you're in the study, you'll need to be seen by your doctor at least once a year. During these annual check-ups, more information will be added to your study record. This includes updates on your diagnosis, any changes to your medication, whether you've had any side effects, and how your overall health and condition are progressing. There are no extra visits or special medications for this study; it simply means your existing care details are being carefully recorded for research purposes over a long period.
Potential risks and benefits
Locations (45)
- Hôpital Reine FabiolaVerified postcodeBrussels, Belgium
- CHU CharleroiVerified postcodeCharleroi, Belgium
- UZ LeuvenVerified postcodeLeuven, Belgium
- CHC LiègeVerified postcodeLiège, Belgium
- CHR CitadelleVerified postcodeLiège, Belgium
- CHU BelfortVerified postcodeBelfort, France
- CHRU BesançonVerified postcodeBesançon, France
- Hôpital Pellegrin enfantsVerified postcodeBordeaux, France
- CHRU BrestVerified postcodeBrest, France
- Hôpital Femme Mère EnfantVerified postcodeBron, France
- CHU Clermont-FerrandVerified postcodeClermont-Ferrand, France
- CHU de GrenobleVerified postcodeGrenoble, France
Common questions
What is 'juvenile inflammatory rheumatism'?
It's a general term for certain types of arthritis and similar conditions that affect children and young people, causing pain, swelling, and stiffness in joints.
Will I have to take any new medicines for this study?
No, this study is about collecting information on the medicines you already take as part of your regular care. You won't be given any new or different treatments specifically for the study.
How often will I need to see the doctor for this study?
You'll continue with your regular doctor's appointments, just like you normally would. The study requires that your information is updated at least once a year during one of these existing visits.
Who will see my personal information?
Your medical information will be handled very carefully and confidentially by authorised researchers and doctors. Steps will be taken to protect your privacy, and often your name won't be directly linked to the data when it's analysed.
Can I stop being part of the study if I change my mind?
Yes, absolutely. You can decide to stop participating at any time you want, without needing to give a reason. Your decision won't affect the medical care you receive.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.